TAKING PARTIAL PROFITS ON ACORDA THERAPEUTICS (ACOR)

Subscribers to ZYX  Short Sell Change Alert took partial profits on Acorda  Therapeutics (ACOR)at $30.20 on Friday. We are holding partial position  for the prices to hit our target zone. This target zone was provided to the subscribers of  ZYX  Short Sell Change Alert at the time of the trade

Read More

LINKEDIN (LNKD): LOW RISK WAYS TO MAKE MONEY

LinkedIn (LNKD) frenzy continues.   Fundamentals do not justify buying LinkedIn  at this level.   LinkedIn is no Google (GOOG). Options will start trading Thursday and stock should become available for shorting after that.   An analysis of the historical data of similar situations shows that shorting this stock in

Read More

ACORDA THERAPEUTICS (ACOR) UP MOVE IS AN OPPORTUNITY

Acorda Therapeutics (ACOR) is up due to the positive opinion on Marketing Authorization Application for its MS drug Ampyra in Europe.  This approval for Acorda Therapeutics was expected.  The big move in Acorda is unwarranted.  We are short selling in the strength now with an average price $32.98 and will add if the

Read More

LIMITED BRANDS (LTD) BOUNCE IS AN OPPORTUNITY TO SELL

Limited Brands (LTD) reported earnings after the close.   The earnings were below the whisper number.   The projections  of  Limited Brands was  less than the published consensus and quite a bit below the whisper numbers. The growth of Limited Brands is clearly slowing.   Bounce in the stock is

Read More

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content